Company / Working Capital per Share
Monte Rosa Therapeutics, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.98
FY2024
5-year range
$2.98 / $13.28
FY2020-FY2024
Trend
-19.1%
vs FY2023
Sector context
#145 of 210
Health Care
What the data says
At $2.98, Monte Rosa Therapeutics, Inc.'s working capital per share ranks #145 of 210 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $13.28 in FY2021 to $2.98 in FY2024.
Based on SEC 10-K filings.
2.98 in FY2024 with a 3-year CAGR of -39.2%.
Declined from $5.30 to $2.98 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -39.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#145 of 210 in Health CareTop 69% of 210This company $2.98 Sector average $146.86
▼
-98.0% below sector average
Key checks
Key Insights
- Monte Rosa Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 19.1% year-over-year.
- Ranks #145 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.98 | -19.1% |
| FY2023 | $3.69 | -30.4% |
| FY2022 | $5.30 | -60.1% |
| FY2021 | $13.28 | +40.7% |
| FY2020 | $9.44 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026